Estrogen therapy in early menopause may help keep arteries clear

By American Heart Association News

SDI Productions/E+, Getty Images
(SDI Productions/E+, Getty Images)

Taking an estrogen pill early in menopause could slow the progress of fatty buildups in the neck arteries, according to new research.

The preliminary study, presented Tuesday at the American Heart Association's Epidemiology and Prevention/Lifestyle and Cardiometabolic Health Scientific Sessions in Phoenix, sheds new light on estrogen therapy's possible impact on plaque buildup in arteries in early versus late menopause.

Researchers analyzed data from ELITE (Early Versus Late Intervention Trial With Estrogen), which studied the cardiovascular health of 643 healthy women who had experienced menopause for less than six years or more than 10 years. Participants received either a daily oral dose of the hormone estradiol – often prescribed to treat symptoms of menopause and to prevent osteoporosis – or a placebo. Every six months for five years, women had ultrasounds of their carotid arteries.

The research focused on lipids, or fatty deposits, that had accumulated on the walls of neck arteries. During early menopause, estradiol therapy reduced the progression of fatty deposits by more than half of that seen in the placebo group.

Among women in late menopause, there was no significant difference in lipid deposits between those taking estradiol and those taking a placebo.

Dr. Roksana Karim, the study's lead author, said the results should help to ease concerns about estrogen therapy that date back to the early 2000s, when some research showed estrogen replacement therapy might actually increase the risk of stroke.

"Because of these misconceptions, some clinicians are still uncomfortable prescribing estradiol therapy," said Karim, associate professor of clinical preventive medicine at the University of Southern California's Keck School of Medicine in Los Angeles. "The ELITE trial results should bring back the confidence in estradiol therapy, which was found safe for women who were recently menopausal, healthy and without any cardiovascular problems."

Because the study focused on early versus late menopause, it left out women who were within six to 10 years of starting menopause. Karim said she'd like to see future studies incorporate those women, and she called for research that delves deeper into cholesterol to find out why estrogen slows plaque buildup in the arteries of some women.

Dr. JoAnn Manson, chief of the division of preventive medicine at Harvard-affiliated Brigham and Women's Hospital in Boston, said the new findings bolster the idea that estrogen therapy has a more favorable effect on cardiovascular health in early menopause.

"The evidence for the timing hypothesis is growing, and it's becoming more compelling," said Manson, who was not involved in the research.

She said the study was limited, however, by its relatively small size and its lack of clinical data on heart attacks and strokes. She cautioned it does not prove estrogen lowers stroke risk, given many other pathways for stroke.

Manson called for research comparing oral estrogen to transdermal estrogen (patches, gels and sprays), as well as studies testing different types of progesterone, another hormone often combined with estrogen.

Because hormone therapy carries some risks, it should not be used "for the express purpose of trying to prevent cardiovascular disease," Manson said.

"But the results of this study are reassuring for the use of estrogen to treat women in early menopause who have bothersome hot flashes or night sweats and would have quality of life benefits from estrogen therapy."

If you have questions or comments about this story, please email [email protected].

American Heart Association News Stories

American Heart Association News covers heart disease, stroke and related health issues. Not all views expressed in American Heart Association News stories reflect the official position of the American Heart Association. Statements, conclusions, accuracy and reliability of studies published in American Heart Association scientific journals or presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect the American Heart Association’s official guidance, policies or positions.

Copyright is owned or held by the American Heart Association, Inc., and all rights are reserved. Permission is granted, at no cost and without need for further request, for individuals, media outlets, and non-commercial education and awareness efforts to link to, quote, excerpt from or reprint these stories in any medium as long as no text is altered and proper attribution is made to American Heart Association News.

Other uses, including educational products or services sold for profit, must comply with the American Heart Association’s Copyright Permission Guidelines. See full terms of use. These stories may not be used to promote or endorse a commercial product or service.

HEALTH CARE DISCLAIMER: This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. If you are in the United States and experiencing a medical emergency, call 911 or call for emergency medical help immediately.